HIF-mediated endothelial response during cancer progression

被引:21
作者
Evans, Colin E. [1 ]
Branco-Price, Cristina [1 ]
Johnson, Randall S. [1 ]
机构
[1] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England
基金
英国惠康基金;
关键词
Cancer; Endothelial; Hypoxia; Metastasis; GROWTH-FACTOR VEGF; OXIDE-GENERATING VASODILATORS; ADHESION MOLECULE-1 ICAM-1; INDUCIBLE FACTOR 1-ALPHA; SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; INTERMITTENT HYPOXIA; TUMOR-CELLS; PROCOAGULANT ACTIVITY; INHIBIT MITOGENESIS;
D O I
10.1007/s12185-012-1072-3
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Tumour growth at primary or secondary extravasation sites leads to localised regions of reduced oxygen tension (hypoxia) in cells both within and surrounding the tumour. Although the angiogenic response of the tumour cell to hypoxia has been widely examined, the effect of hypoxia on other cell types within the tumour microenvironment is less clear. The endothelium is highly responsive to local hypoxia and regulates tumour cell dissemination and ultimately metastatic success through differential regulation of hypoxia-inducible transcription factors (HIFs). The endothelial response to hypoxia particularly mediates key processes that regulate tumour vascularisation and cancer progression, including proliferation, migration, adherence, and vascular permeability. This article describes current understanding of the HIF-mediated endothelial response to hypoxia during cancer progression. Endothelial HIF signalling regulates tumour growth and metastasis and is therefore an attractive putative target for treatments that inhibit cancer progression.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 75 条
[1]
LEUKOCYTE-ENDOTHELIAL INTERACTIONS AND REGULATION OF LEUKOCYTE MIGRATION [J].
ADAMS, DH ;
SHAW, S .
LANCET, 1994, 343 (8901) :831-836
[2]
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[3]
Signaling of the tissue factor coagulation pathway in angiogenesis and cancer [J].
Belting, M ;
Ahamed, J ;
Ruf, W .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1545-1550
[4]
Genetic Link Between Cancer and Thrombosis [J].
Boccaccio, Carla ;
Comoglio, Paolo M. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (29) :4827-4833
[5]
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid [J].
Bottomley, MJ ;
Webb, NJA ;
Watson, CJ ;
Holt, L ;
Bukhari, M ;
Denton, J ;
Freemont, AJ ;
Brenchley, PEC .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (01) :182-188
[6]
Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success [J].
Branco-Price, Cristina ;
Zhang, Na ;
Schnelle, Moritz ;
Evans, Colin ;
Katschinski, Doerthe M. ;
Liao, Debbie ;
Ellies, Lesley ;
Johnson, Randall S. .
CANCER CELL, 2012, 21 (01) :52-65
[7]
BUTLER TP, 1975, CANCER RES, V35, P512
[8]
VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[9]
NO and angiogenesis [J].
Cooke, JP .
ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (04) :53-60
[10]
Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter [J].
Coulet, F ;
Nadaud, S ;
Agrapart, M ;
Soubrier, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :46230-46240